I am really excited to share with you that Theravent and Talk About Sleep are partnering to help build and expand the conversation around snoring including its causes, effects, and remedies. We are collaborating to expand and educate this robust community, while giving the average snorer more representation and resources online.
To facilitate educating and connecting those in the snoring community, Theravent will lend its expertise to offer snorers solutions as well as promote the importance of recognizing snoring as a sleep disorder. Theravent plans to use its knowledge-base to share the latest innovations and research and feature insights from respected sleep experts. Towards this end, Talk About Sleep has added multiple levels of exciting and insightful content including general information, diagnosis, treatment and disease management. In addition, a snoring forum has been added which I will moderate. I look forward to connecting with you via the forum and I hope you will participate.
Through this collaboration, it is our hope to raise awareness about snoring and its widespread impact on the health and well-being of the patient community and their bed partners.
Talk About Sleep community members will also receive a special offer from Theravent who offer two distinct snore remedies: TheraventTM Advanced Nightly Snore Therapy for individuals who snore and Provent Sleep Apnea Therapy for individuals who have been diagnosed with sleep apnea by their doctor.
Theravent has already been working hard to help alleviate the symptoms of snoring with its products. Through clinical trials, Theravent Advanced Nightly Snore Therapy has been proven to significantly reduce snoring by an average of 76% helping both the snorer and their bed partner achieve a better night’s sleep. Theravent uses the power of the snorer’s own breath to maintain an open airway throughout the night thus reducing the occurrences of snoring.
Matthew Williams, Theravent Inc, President & Chief Executive Officer
Mr. Williams has served as the Company’s President and CEO since the Company’s launch in April 2013. Mr. Williams is responsible for managing all day-to-day operations of the Company, and developing and implementing strategies approved by the Board.
Mr. Williams brings to the company management experience in the pharmaceuticals, medical devices and consumer health industries. Prior to starting the Company, Mr. Williams spent 3 years with Ventus Medical as Director of Sales and 13 years with Johnson and Johnson, in multiple sales and marketing roles. While at Ventus, he built the sales strategy for the Provent Prescription Franchise and was an active contributor on the Senior Leadership Team. While at Johnson and Johnson, he led the Trade Marketing team focused on growth strategies in the combined $800MM Retail Pharmacy, Chain Drug and Grocery Pharmacy segments of the Diabetes Franchise. In addition, Matt created and led the Sales Leadership Development Program focusing on the development of the leadership pipeline across multiple functional areas within the business.
Mr. Williams has also held management positions at Ortho-McNeil, Janssen Pharmceutica and Hoechst Marion Rouss.
Theravent, Inc. is a privately-held medical device company dedicated to providing non-invasive medical solutions for people with sleep-disordered breathing. Based on its innovative MicroValve technology and patented designs, Theravent, Inc. has developed a unique line of clinically-proven medical devices to address the continuum of sleep disorders from severe obstructive sleep apnea (OSA) to mild snoring. The company markets Provent Sleep Apnea Therapy, a discreet, easy-to-use nasal device, for the treatment of obstructive sleep apnea and Theravent Advanced Nightly Snore Therapy an over-the-counter device for the treatment of snoring in the U.S., Canada, Australia, and New Zealand. Theravent received FDA clearance in June of 2012 and is not intended to treat obstructive sleep apnea.